Riomet ER™ (metformin) – New formulation approval
August 29, 2019 - The FDA approved Sun Pharmaceuticals’ Riomet ER (metformin) oral suspension, as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.
Download PDF
